USPTO serial 79296535
CUEPEAK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 6, 2021
- Examiner
- BROWNE, LUCY E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CUEPEAK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Deodorants for animals; non-medicated grooming preparations in the nature of shampoos for animals; cosmetics for animals; pre-moistened cleansing tissues, namely, disposable wipes impregnated with skin cleansers | ACTIVE | — |
| 005 | Analgesics; veterinary preparations, namely, antioxidants, pain relief medication; hair growth stimulants; anti-inflammatory preparations; allergy medications; pharmaceutical preparations and compositions for the treatment and prevention of cancer; syringes sold filled with analgesics, anti-inflammatory preparations, allergy medications for medical purposes; biological preparations for medical or veterinary purposes for the treatment of intestinal bacteria, cancer; biochemical preparations for medical or veterinary purposes, namely, preparations for blood analysis; diagnostic biomarker reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; enzymes for medical purposes; chemical reagents for medical or veterinary purposes; chemical preparations for medical or veterinary purposes, namely, for the treatment of intestinal bacteria, cancer; topical gels for medical and therapeutic treatment of intestinal bacteria, cancer; medicated skin care preparations, namely, lotions and creams for the body, skin, face, and hands; adjuvants for medical purposes; diagnostic reagents and contrast media for medical use; probiotic preparations for medical use; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in dermatology; solutions, namely, gels, creams for dermatological use; pharmaceutical preparations for skin care; anti-cancer preparations; tissues impregnated with antibacterial preparations; antibiotic preparations; preparations for the treatment of burns; pharmaceutical preparations for use in chemotherapy; chemotherapeutics; nutraceutical preparations for therapeutic or medical purposes for promoting digestion, use as a dietary supplement; cotton swabs for medical use impregnated with antibacterial preparations; pre-moistened medicated wipes; pre-moistened medicated tissues | ACTIVE | — |
| 009 | Biochips for research or scientific purposes; biochip sensors for monitoring a person's vital signs and body temperature; laboratory gene amplifiers in the nature of DNA microarrays; DNA microarrays, namely, DNA chips | ACTIVE | — |
| 010 | Medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA; diagnostic imaging apparatus for medical use, namely, for testing blood sugar levels, cancer cells, DNA | ACTIVE | — |
| 042 | Drug discovery services; scientific research for medical purposes in the field of cancerous diseases; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical product evaluation; medical and pharmacological research services; medical research; medical and scientific research, namely, conducting clinical trials for others; scientific research, namely conducting clinical trials for others; blood analysis services for scientific research purposes; basic and clinical research in the field of respiratory science and medicine; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; cosmetics research; research and development services in the field of cosmetics; research and consultancy in the field of zoology; research and development services in the field of biotechnology; biotechnological research services in the field of genetics, enzyme synthesis; biomedical research services; biological research; biochemical research and analysis; research and development services in the field of biochemistry; biochemical research and development; scientific research in the field of genetics and genetic engineering; chemical engineering | ACTIVE | — |
| 044 | Medical and pediatric, integrated outpatient, and managed health care services; medical consultations; providing information in the field of medicine; medical and health services relating to DNA screening, genetic counseling, and genetic testing; health screening services in the field of asthma, sleep apnea; physical examination services; health clinic services; medical services, namely, treatment of chronic pain; medical analysis for the diagnosis and treatment of persons; laboratory analysis services relating to the treatment of persons; medical services relating to the removal, treatment and processing of human blood; medical analysis services, namely, RNA and DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; health care services for treating cancer; providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical and health care clinic services; medical examination services; rental of medical apparatus and sanitary installations; rental of medical and health care equipment; medical assistance; medical analysis services relating to the treatment of persons; lifestyle counselling and consultancy for medical purposes; drug, alcohol and DNA screening for medical purposes; storage of human cells for medical use; providing medical consultancy and information services relating to medical products; medical diagnostic testing, monitoring, and reporting services; medical evaluation services, namely, functional assessment program for patients receiving medical rehabilitation services for purposes of guiding treatment and assessing program effectiveness; medical imaging services; mobile medical clinic services; medical services, namely, pathology services relating to the diagnosis and treatment of diseases in persons; medical services relating to the removal, treatment and processing of human cells; human tissue bank services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; performing diagnosis of diseases; cognitive, occupational, and stem cell therapy services; dermatology services; medical services for the treatment of skin cancer; medical laboratory services for the analysis of blood samples taken from patients for medical diagnostic purposes; genetic testing of animals for diagnostic or treatment purposes; laboratory analysis services for diagnostic and treatment purposes relating to the treatment of animals; veterinary services and providing information relating thereto | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CUePEAK BIO. Co.,Ltd.
- Other trademarks owned by CUePEAK BIO. Co.,Ltd.
- Other trademarks owned by CUePEAK BIO. Co.,Ltd.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CUEPEAK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 29, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 9, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 9, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 6, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 6, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 19, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 31, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 31, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 31, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 16, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 16, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 16, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 12, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 11, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 11, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 30, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 31, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |